FR22C1045I2 - Conjugués protéine-polymère - Google Patents

Conjugués protéine-polymère

Info

Publication number
FR22C1045I2
FR22C1045I2 FR22C1045C FR22C1045C FR22C1045I2 FR 22C1045 I2 FR22C1045 I2 FR 22C1045I2 FR 22C1045 C FR22C1045 C FR 22C1045C FR 22C1045 C FR22C1045 C FR 22C1045C FR 22C1045 I2 FR22C1045 I2 FR 22C1045I2
Authority
FR
France
Prior art keywords
protein
polymer conjugates
conjugates
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR22C1045C
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PharmaEssentia Corp
Original Assignee
PharmaEssentia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40351178&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR22C1045(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by PharmaEssentia Corp filed Critical PharmaEssentia Corp
Publication of FR22C1045I1 publication Critical patent/FR22C1045I1/fr
Application granted granted Critical
Publication of FR22C1045I2 publication Critical patent/FR22C1045I2/fr
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K17/00Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02Peptides being immobilised on, or in, an organic carrier
    • C07K17/08Peptides being immobilised on, or in, an organic carrier the carrier being a synthetic polymer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR22C1045C 2007-08-16 2022-08-26 Conjugués protéine-polymère Active FR22C1045I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95627307P 2007-08-16 2007-08-16
PCT/US2008/073290 WO2009023826A1 (fr) 2007-08-16 2008-08-15 Conjugués protéine-polymère

Publications (2)

Publication Number Publication Date
FR22C1045I1 FR22C1045I1 (fr) 2022-10-14
FR22C1045I2 true FR22C1045I2 (fr) 2023-12-29

Family

ID=40351178

Family Applications (1)

Application Number Title Priority Date Filing Date
FR22C1045C Active FR22C1045I2 (fr) 2007-08-16 2022-08-26 Conjugués protéine-polymère

Country Status (30)

Country Link
US (1) US8143214B2 (fr)
EP (2) EP2205281B1 (fr)
JP (1) JP5613050B2 (fr)
KR (1) KR101588465B1 (fr)
CN (1) CN101367872B (fr)
AR (1) AR067964A1 (fr)
AU (1) AU2008286742B2 (fr)
BR (1) BRPI0814482B8 (fr)
CA (1) CA2696478C (fr)
CL (1) CL2008002399A1 (fr)
CY (1) CY1125751T1 (fr)
DK (1) DK2205281T3 (fr)
EA (1) EA018111B1 (fr)
ES (1) ES2924727T3 (fr)
FR (1) FR22C1045I2 (fr)
HR (1) HRP20220937T3 (fr)
HU (2) HUE059551T2 (fr)
LT (1) LT2205281T (fr)
MX (1) MX2010001750A (fr)
MY (1) MY149148A (fr)
NL (1) NL301195I2 (fr)
NO (1) NO2022038I1 (fr)
NZ (1) NZ583831A (fr)
PL (1) PL2205281T3 (fr)
PT (1) PT2205281T (fr)
SI (1) SI2205281T1 (fr)
TW (1) TWI381851B (fr)
UA (1) UA103158C2 (fr)
WO (1) WO2009023826A1 (fr)
ZA (1) ZA201001777B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI421093B (zh) * 2008-07-31 2014-01-01 Pharmaessentia Corp 胜肽-聚合物綴合物
UA109646C2 (uk) * 2009-12-10 2015-09-25 Терапевтичне застосування кон'югатів білка з полімером
EA037151B1 (ru) 2014-11-06 2021-02-11 Фармаэссентия Корпорейшн Способ лечения с использованием пегилированного интерферона
CN112433048A (zh) * 2020-11-17 2021-03-02 深圳上泰生物工程有限公司 一种用于化学发光免疫法的试剂盒及其制备方法和应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR850004274A (ko) 1983-12-13 1985-07-11 원본미기재 에리트로포이에틴의 제조방법
US5919455A (en) * 1993-10-27 1999-07-06 Enzon, Inc. Non-antigenic branched polymer conjugates
US5643575A (en) 1993-10-27 1997-07-01 Enzon, Inc. Non-antigenic branched polymer conjugates
US5951974A (en) 1993-11-10 1999-09-14 Enzon, Inc. Interferon polymer conjugates
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
US5932462A (en) * 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
TW517067B (en) * 1996-05-31 2003-01-11 Hoffmann La Roche Interferon conjugates
JP2003527090A (ja) * 1999-08-27 2003-09-16 マキシゲン・エイピーエス 新規なインターフェロンベータ様分子
SK8292002A3 (en) * 1999-11-12 2002-12-03 Maxygen Holdings Ltd A conjugate exhibiting interferon gamma activity, nucleotide sequence encoding for a polypeptide fraction of conjugate, an expression vector and a host cell containing nucleotide sequence, pharmaceutical composition comprising the same and use thereof
US7125843B2 (en) * 2001-10-19 2006-10-24 Neose Technologies, Inc. Glycoconjugates including more than one peptide
AU2002356990A1 (en) * 2001-11-20 2003-06-10 Pharmacia Corporation Chemically-modified human growth hormone conjugates
US20030171285A1 (en) * 2001-11-20 2003-09-11 Finn Rory F. Chemically-modified human growth hormone conjugates
WO2003061577A2 (fr) 2002-01-18 2003-07-31 Biogen Idec Ma Inc. Composes polymeres de polyalkylene et utilisations de ceux-ci
US7345150B2 (en) 2002-03-26 2008-03-18 Medical University Of Toledo Albumin-based colloid composition having at least one protected thiol region, methods of making, and methods of use
JP4764630B2 (ja) 2002-09-09 2011-09-07 ネクター セラピューティックス 水溶性ポリマーアルカナール
CA2510040C (fr) * 2003-05-23 2012-01-03 Nektar Therapeutics Al, Corporation Reactifs polymeriques et conjugues polymeres-biomolecules comportant des liens carbamate
US20070254834A1 (en) * 2003-11-24 2007-11-01 Defrees Shawn Glycopegylated Erythropoietin
AP2007003919A0 (en) 2004-08-31 2007-02-28 Pharmacia & Upjohn Co Llc Glycerol branched polyethylene glycol human growthhormone conjugates, process for their prepation a nd methods of use thereof
US7365127B2 (en) * 2005-02-04 2008-04-29 Enzon Pharmaceuticals, Inc. Process for the preparation of polymer conjugates
EP1869079A2 (fr) * 2005-03-11 2007-12-26 Siegfried Ltd. Conjugues di-polymere-proteine et procedes de preparation de ceux-ci
WO2006094530A1 (fr) * 2005-03-11 2006-09-14 Siegfried Ltd. Conjugues de proteines et de dipolymeres et leurs procedes de preparation
CN101002944B (zh) 2006-01-17 2012-07-25 中国科学院过程工程研究所 支链聚乙二醇-干扰素结合物及其制备方法
CN101104078B (zh) 2006-07-11 2011-11-02 北京美倍他药物研究有限公司 多肽及蛋白药物的聚乙二醇偶合物
CN101108895B (zh) 2006-07-19 2011-10-26 北京键凯科技有限公司 聚乙二醇乙醛衍生物及其与药物的结合物
CN1966547B (zh) 2006-11-06 2011-11-09 中国药科大学 双链结构的聚乙二醇衍生物的制备及其与药物分子的结合
CN1970572A (zh) 2006-12-21 2007-05-30 北京三元基因工程有限公司 干扰素α突变体及其聚乙二醇衍生物
PT2186830E (pt) 2007-09-04 2012-06-20 Biosteed Gene Expression Tech Co Ltd Interferão alfa 2b modificado com polietilenoglicol e método de preparação e aplicações do mesmo
US8597634B2 (en) 2007-09-04 2013-12-03 Biosteed Gene Expression Tech. Co., Ltd. Interferon alpha-2a modified by polyethylene glycol and methods of preparation thereof
CN101491682A (zh) 2008-04-30 2009-07-29 北京凯正生物工程发展有限责任公司 聚乙二醇化重组人干扰素ω偶合物及其制备工艺
CN101671390B (zh) 2008-09-10 2012-10-03 海南四环心脑血管药物研究院有限公司 人干扰素α衍生物及其聚乙二醇化修饰物的制备和用途
CN101514229B (zh) 2009-04-03 2012-05-09 海南四环心脑血管药物研究院有限公司 人干扰素α衍生物及其聚乙二醇化修饰物

Also Published As

Publication number Publication date
CN101367872A (zh) 2009-02-18
EP4129343A1 (fr) 2023-02-08
NL301195I1 (fr) 2022-08-31
AU2008286742A1 (en) 2009-02-19
PL2205281T3 (pl) 2022-12-12
CA2696478A1 (fr) 2009-02-19
LT2205281T (lt) 2022-09-26
FR22C1045I1 (fr) 2022-10-14
MY149148A (en) 2013-07-15
TWI381851B (zh) 2013-01-11
KR20100076945A (ko) 2010-07-06
HRP20220937T3 (hr) 2022-09-30
EP2205281A1 (fr) 2010-07-14
TW200916116A (en) 2009-04-16
NL301195I2 (nl) 2023-03-02
CA2696478C (fr) 2018-10-09
HUE059551T2 (hu) 2022-11-28
MX2010001750A (es) 2010-06-01
AU2008286742B2 (en) 2014-05-29
WO2009023826A1 (fr) 2009-02-19
JP5613050B2 (ja) 2014-10-22
HUS2200039I1 (hu) 2022-09-28
US8143214B2 (en) 2012-03-27
ZA201001777B (en) 2010-12-29
BRPI0814482B8 (pt) 2021-11-23
EA018111B1 (ru) 2013-05-30
UA103158C2 (ru) 2013-09-25
DK2205281T3 (da) 2022-08-15
EA201070282A1 (ru) 2010-08-30
PT2205281T (pt) 2022-08-02
BRPI0814482A2 (pt) 2015-02-03
CN101367872B (zh) 2013-11-20
ES2924727T3 (es) 2022-10-10
CL2008002399A1 (es) 2009-01-02
NO2022038I1 (no) 2022-09-02
NZ583831A (en) 2012-06-29
BRPI0814482B1 (pt) 2021-02-02
CY1125751T1 (el) 2023-06-09
KR101588465B1 (ko) 2016-01-25
US20090053177A1 (en) 2009-02-26
SI2205281T1 (sl) 2022-11-30
AR067964A1 (es) 2009-10-28
EP2205281B1 (fr) 2022-06-29
JP2010536788A (ja) 2010-12-02
EP2205281A4 (fr) 2014-10-08

Similar Documents

Publication Publication Date Title
NL301207I1 (nl) tezepelumab
BRPI0821573A2 (pt) benzofuropirimidonas
ATE514696T1 (de) Diphenyl-dihydro-imidazopyridinone
DE112008003636A5 (de) Mehrzuggruppierer
DE502007001207D1 (de) Elektrosaugkopf
BRPI0814519A2 (pt) Organopolissiloxano
BRPI0811451A2 (pt) Exopolissacarídeo
DK2125048T3 (da) Præparat
BRPI0812840A2 (pt) 2-imidazolinas
AT505058A3 (de) Türschliesssystem
BRPI0812994A2 (pt) Microbiocidas
FR22C1045I2 (fr) Conjugués protéine-polymère
DE112008001216A5 (de) Magnetronplasmaanlage
DE502008001694D1 (de) Mitfahrhubwagen
DE112008003094A5 (de) Geomatte
DE502008003063D1 (de) Magnetventilinjektor
DE112008002200A5 (de) Sperrsynchronisiervorrichtung
DE602008000292D1 (de) Werkzeughaltepositioniervorrichtung
DE112008002909A5 (de) Verwahrbehältnis
DE502008000815D1 (de) Kraftfahrzeugsitzverstellantrieb
DE112008001534A5 (de) Anreihgussform
DE502007005002D1 (de) Durchlaufsägevorrichtung
DE602007008359D1 (de) Hemdendbearbeitungsmaschine
DE112008003669A5 (de) Abkühlanordnung
DE502008002186D1 (de) Ringextruder